Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders.
Pediatr Nephrol
; 37(6): 1387-1397, 2022 06.
Article
em En
| MEDLINE
| ID: mdl-34693482
ABSTRACT
BACKGROUND:
Continuous kidney replacement therapies (CKRT) have been reported to be an effective approach to removing toxic metabolites in inborn errors of metabolism (IEM). The present study evaluates efficiency and complications of CKRT in children with IEM.METHODS:
Patients diagnosed with IEM who underwent CKRT in pediatric and neonatal intensive care units were analyzed. CKRT were initiated in patients with persistently high blood ammonia levels (≥ 500 µmol/L), blood ammonia levels > 250 µmol/L in the presence of moderate encephalopathy, high blood leucine levels (≥ 1500 µmol/L), and blood leucine levels < 1500 µmol/L in the presence of deteriorating neurological status or persistent metabolic acidosis.RESULTS:
Of 22 patients enrolled, nine (40.9%) Maple syrup urine disease (MSUD), eight (36.4%) urea cycle disorders (UCD), and five (22.7%) organic acidemias (OA). Median age was 72.3 [9.9-1040.8] days. In total, 28 dialysis sessions were analyzed [16 (57.1%) continuous venovenous hemodialysis, and 12 (42.9%) continuous venovenous hemodiafiltration]. A significant decrease was noted in leucine levels (from 1608.4 ± 885.3 to 314.6 ± 109.9 µmol/L) of patients with MSUD, while ammonia levels were significantly decreased in patients with UCD and OA (from 1279.9 ± 612.1 to 85.1 ± 21.6 µmol/L). The most frequent complications of CKRT were thrombocytopenia (60.7%), hypotension (53.6%), and hypocalcemia (42.9%). Median age of patients with hypotension treated with vasoactive medications was significantly lower than median age of those with normal blood pressure.CONCLUSION:
CKRT is a reliable approach for effective and rapid removal of toxic metabolites in children with IEM, and CKRT modalities can be safely used and are well-tolerated in infants.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Hemodiafiltração
/
Terapia de Substituição Renal Contínua
/
Hipotensão
/
Doença da Urina de Xarope de Bordo
/
Doenças Metabólicas
/
Erros Inatos do Metabolismo
Tipo de estudo:
Etiology_studies
Limite:
Aged
/
Child
/
Humans
/
Infant
/
Newborn
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article